Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-08-16

FDA Approved: ANAGRELIDE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for Anagrelide by Torrent Pharmaceuticals Limited, updating the labeling for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANAGRELIDE (Anagrelide)

Snippet

SUPPL AP for ANAGRELIDE (ANAGRELIDE)